Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Recombinant vs Inactivated COVID-19 Vaccine Booster
NCT05033847Phase 2Unknown
- Sponsor
- Serum Institute of India
- Start
- Sep 2021
- Primary completion
- Nov 2023
- Modality
- Recombinant Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of NVSI-06-07 in coronavirus disease 2019 (COVID-19), sponsored by Serum Institute of India. Status: unknown.
02
Drugs
NVSI-06-07
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05033847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05033847.